Latest Breaking News On - Per svenningsson - Page 1 : vimarsana.com

IntelGenx Announces First Parkinson s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 MONTPARK Clinical Trial -April 08, 2024 at 07:45 am EDT

SAINT LAURENT, Quebec, April 08, 2024 IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical.

United statesSaint laurentDwight gorhamStephen kilmerAndre godinMontelukast versafilmExchange commissionIntelgenx corpDrug administrationSwedish universityIntelgenx technologies corpWorld health organizationParkinson foundationSecurities exchangeKarolinska university hospitalCompany or intelgenx

IntelGenx Announces First Parkinson s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK Clinical Trial

IntelGenx Announces First Parkinson s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK Clinical Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Saint laurentUnited statesMontelukast versafilmStephen kilmerAndre godinDwight gorhamIntelgenx technologies corpCompany or intelgenxIntelgenx corpExchange commissionSwedish universityParkinson foundationKarolinska university hospitalWorld health organizationSecurities exchangeDrug administration

IntelGenx Receives Approval to Conduct MONTPARK Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson s Disease

IntelGenx Receives Approval to Conduct MONTPARK Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSaint laurentStephen kilmerIntelgenx montelukast versafilmDwight gorhamAndre godinMontelukast versafilmIntelgenx corpSwedish universitySwedish research councilIntelgenx technologies corpExchange commissionRegional biobank centreSwedish ethical review authorityCompany or intelgenxSecurities exchange

IntelGenx Technologies Corp (PNK:IGXT) Q3 2023 Earnings Call Transcript

Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Frank pietrantonioGensco pharmaDwight gorhamAndre godinHugh kellyMontelukast versafilmStephen kilmerHorst zerbeTommy kennyHealth canadaLife sciencesIntelgenx technologies corpClinical researchSwedish research councilKarolinska university hospitalBrd group

IntelGenx Reports Third Quarter 2023 Financial Results

SAINT LAURENT, Quebec, Nov. 09, 2023 (GLOBE NEWSWIRE) IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the Company or IntelGenx ) toda.

United statesSaint laurentGensco pharmaMontelukast verafilmAndre godinMontelukast versafilmStephen kilmerIntelgenx montelukast versafilmIntelgenx corpExchange commissionChemo researchTilray brands incLife sciencesSecurities exchangeDrug administrationCompany or intelgenx